OCA
BBOT

Octagon Capital Advisors’s BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT Stock Holding History

Octagon Capital Advisors’s Portfolio BBOT Stock Details BBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$2.66M Hold
250,000
– – 0.58% 26
2025
Q1 		$2.83M Hold
250,000
– – 0.55% 34
2024
Q4 		$2.63M Hold
250,000
– – 0.43% 29
2024
Q3 		$2.61M Hold
250,000
– – 0.41% 31
2024
Q2 		$2.56M Hold
250,000
– – 0.4% 33
2024
Q1 		$2.59M Buy
+250,000
New +$2.59M 0.31% 50